Hydrogenics Corp. (HYGS) Given a $13.00 Price Target at Roth Capital
Separately, Zacks Investment Research upgraded shares of Hydrogenics Corp. from a sell rating to a hold rating in a report on Wednesday, October 5th.
Shares of Hydrogenics Corp. (NASDAQ:HYGS) traded down 0.75% on Monday, hitting $6.60. 47,689 shares of the company’s stock were exchanged. The company’s 50-day moving average price is $5.78 and its 200 day moving average price is $7.15. Hydrogenics Corp. has a 12-month low of $4.65 and a 12-month high of $12.08. The stock’s market cap is $82.79 million.
Hydrogenics Corp. (NASDAQ:HYGS) last announced its quarterly earnings data on Wednesday, August 3rd. The company reported ($0.25) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.16) by $0.09. Hydrogenics Corp. had a negative net margin of 28.32% and a negative return on equity of 64.61%. The firm earned $9.20 million during the quarter, compared to analyst estimates of $11.40 million. On average, equities analysts predict that Hydrogenics Corp. will post ($0.73) earnings per share for the current fiscal year.
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Wolverine Asset Management LLC increased its position in Hydrogenics Corp. by 7.6% in the second quarter. Wolverine Asset Management LLC now owns 351,468 shares of the company’s stock worth $2,425,000 after buying an additional 24,698 shares during the period. Veritable L.P. bought a new position in Hydrogenics Corp. during the second quarter worth approximately $297,000. GAM Holding AG increased its position in Hydrogenics Corp. by 31.7% in the second quarter. GAM Holding AG now owns 299,914 shares of the company’s stock worth $2,069,000 after buying an additional 72,177 shares during the period. Societe Generale bought a new position in Hydrogenics Corp. during the second quarter worth approximately $414,000. Finally, DNB Asset Management AS increased its position in Hydrogenics Corp. by 16.7% in the second quarter. DNB Asset Management AS now owns 30,965 shares of the company’s stock worth $214,000 after buying an additional 4,440 shares during the period. 32.00% of the stock is currently owned by hedge funds and other institutional investors.
Hydrogenics Corp. Company Profile
Hydrogenics Corporation designs, develops and manufactures hydrogen generation products based on water electrolysis technology, and fuel cell products based on proton exchange membrane (PEM) technology. The Company’s segments are Onsite Generation and Power Systems. The OnSite Generation segment is based in Oevel, Belgium and develops products for industrial gas, hydrogen fueling and renewable energy storage markets.
Receive News & Stock Ratings for Hydrogenics Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hydrogenics Corp. and related stocks with our FREE daily email newsletter.